CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 626265-626390 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"The primary efficacy endpoint was the change from baseline in Total Symptom Severity Complex (TSSC) score at 12 hr post-dose.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T22826","span":{"begin":0,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T22826","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T360","span":{"begin":0,"end":125},"obj":"Sentence"}],"attributes":[{"subj":"T360","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5860","span":{"begin":30,"end":33},"obj":"Disease"}],"attributes":[{"id":"A5860","pred":"mondo_id","subj":"T5860","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T5860","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#eca093","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93a0ec"},{"id":"CORD-19-PD-MONDO","color":"#baec93"}]}]}}